Pharmaceutical Evaluation of Levofloxacin Orally Disintegrating Tablet Formulation Using Low Frequency Raman Spectroscopy.

Yamamoto, Yoshihisa; Kajita, Mizuho; Hirose, Yutaro; Shimada, Naoki; Fukami, Toshiro; Koide, Tatsuo.

Afiliação

Yamamoto Y; Faculty of Pharmaceutical Sciences, Teikyo Heisei University, 4-21-2 Nakano, Nakano-ku, Tokyo 164-8530, Japan.
Kajita M; Bio & Healthcare Division, HORIBA Ltd., 2 Miyanohigashi-cho, Kisshoin, Minami-ku, Kyoto 601-8510, Japan.
Hirose Y; Bio & Healthcare Division, HORIBA Ltd., 2 Miyanohigashi-cho, Kisshoin, Minami-ku, Kyoto 601-8510, Japan.
Shimada N; Department of Molecular Pharmaceutics, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose-shi, Tokyo 204-8588, Japan.
Fukami T; Department of Molecular Pharmaceutics, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose-shi, Tokyo 204-8588, Japan.
Koide T; Division of Drugs, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki 210-9501, Japan.

Pharmaceutics ; 15(8)2023 Jul 29.

Article em En | MEDLINE | ID: mdl-37631255